Literature DB >> 25386033

Vaccine against human papilloma virus.

Julio C Reina1, Nubia Muñoz2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25386033      PMCID： PMC4225784     

Source DB:  PubMed          Journal:  Colomb Med (Cali)        ISSN： 0120-8322


× No keyword cloud information.
  7 in total

1.  Updated aluminum pharmacokinetics following infant exposures through diet and vaccination.

Authors:  Robert J Mitkus; David B King; Maureen A Hess; Richard A Forshee; Mark O Walderhaug
Journal:  Vaccine       Date:  2011-10-11       Impact factor: 3.641

2.  Autoimmune disorders and quadrivalent human papillomavirus vaccination of young female subjects.

Authors:  L Grimaldi-Bensouda; D Guillemot; B Godeau; J Bénichou; C Lebrun-Frenay; C Papeix; P Labauge; P Berquin; A Penfornis; P-Y Benhamou; M Nicolino; A Simon; J-F Viallard; N Costedoat-Chalumeau; M-F Courcoux; C Pondarré; P Hilliquin; E Chatelus; V Foltz; S Guillaume; M Rossignol; L Abenhaim
Journal:  J Intern Med       Date:  2013-11-22       Impact factor: 8.989

Review 3.  Mass psychogenic response to human papillomavirus vaccination.

Authors:  Jim P Buttery; Simon Madin; Nigel W Crawford; Sonja Elia; Sophie La Vincente; Sarah Hanieh; Lindsay Smith; Bruce Bolam
Journal:  Med J Aust       Date:  2008-09-01       Impact factor: 7.738

4.  Monitoring the safety of quadrivalent human papillomavirus vaccine: findings from the Vaccine Safety Datalink.

Authors:  Julianne Gee; Allison Naleway; Irene Shui; James Baggs; Ruihua Yin; Rong Li; Martin Kulldorff; Edwin Lewis; Bruce Fireman; Matthew F Daley; Nicola P Klein; Eric S Weintraub
Journal:  Vaccine       Date:  2011-09-09       Impact factor: 3.641

5.  Impact of human papillomavirus (HPV)-6/11/16/18 vaccine on all HPV-associated genital diseases in young women.

Authors:  Nubia Muñoz; Susanne K Kjaer; Kristján Sigurdsson; Ole-Erik Iversen; Mauricio Hernandez-Avila; Cosette M Wheeler; Gonzalo Perez; Darron R Brown; Laura A Koutsky; Eng Hseon Tay; Patricía J Garcia; Kevin A Ault; Suzanne M Garland; Sepp Leodolter; Sven-Eric Olsson; Grace W K Tang; Daron G Ferris; Jorma Paavonen; Marc Steben; F Xavier Bosch; Joakim Dillner; Warner K Huh; Elmar A Joura; Robert J Kurman; Slawomir Majewski; Evan R Myers; Luisa L Villa; Frank J Taddeo; Christine Roberts; Amha Tadesse; Janine T Bryan; Lisa C Lupinacci; Katherine E D Giacoletti; Heather L Sings; Margaret K James; Teresa M Hesley; Eliav Barr; Richard M Haupt
Journal:  J Natl Cancer Inst       Date:  2010-02-05       Impact factor: 13.506

6.  Postlicensure safety surveillance for quadrivalent human papillomavirus recombinant vaccine.

Authors:  Barbara A Slade; Laura Leidel; Claudia Vellozzi; Emily Jane Woo; Wei Hua; Andrea Sutherland; Hector S Izurieta; Robert Ball; Nancy Miller; M Miles Braun; Lauri E Markowitz; John Iskander
Journal:  JAMA       Date:  2009-08-19       Impact factor: 56.272

7.  Autoimmune, neurological, and venous thromboembolic adverse events after immunisation of adolescent girls with quadrivalent human papillomavirus vaccine in Denmark and Sweden: cohort study.

Authors:  Lisen Arnheim-Dahlström; Björn Pasternak; Henrik Svanström; Pär Sparén; Anders Hviid
Journal:  BMJ       Date:  2013-10-09
  7 in total
  1 in total

1.  Perception about barriers and facilitators of the school-based HPV vaccine program of Manizales, Colombia: A qualitative study in school-enrolled girls and their parents.

Authors:  Verónica Cordoba-Sanchez; Olga Lucía Tovar-Aguirre; Sandra Franco; Nelson Enrique Arias Ortiz; Karly Louie; Gloria Ines Sanchez; Isabel C Garces-Palacio
Journal:  Prev Med Rep       Date:  2019-08-22
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.